Express Pharma - Page 1349 of 2184 - Express Pharma

Supriya Lifescience receives USFDA EIR with VAI classification for Lote Parshuram facility

Off label drug use and physician liability

Lupin launches Dapagliflozin and Metformin extended-release tablets in the United States

Strides Shasun divests India brand business to Eris Lifesciences for Rs 500 cr

Zydus Cadila gets US FDA nod for drug used to reduce swelling

Cipla receives US FDA approval for generic Pulmicort Respules

OPTEL Group bags loan worth CAD $68 m from Desjardins Group

Mylan launches DURART R 450

Suven gets patents from HK, India, US on neurological molecule

Glenmark launches Kwitz

First made-in-India ‘digital pill’ to undergo clinical trial for diabetes

Panacea Biotec in agreement with Technology Development Board, Govt. of India

Sun Pharma posts net profit of Rs 912 crores in Q2FY18